Education Hub
Foundations
Paradise Farmers Market

What is Ibogaine?

12 min read
Curated by Paradise Farmers Market

The Basics

Ibogaine is a naturally occurring psychoactive alkaloid found in the root bark of Tabernanthe iboga, a perennial shrub native to the rainforests of Central West Africa, primarily Gabon and Cameroon. It belongs to the indole alkaloid family and is one of at least 12 alkaloids found in the iboga plant.

Unlike most psychedelics, ibogaine produces a unique, extended experience lasting 24–36 hours, characterized by two distinct phases: an initial visionary phase (4–8 hours) with vivid, dream-like sequences, followed by an introspective phase (8–20 hours) involving deep self-reflection and processing of memories and emotions.

Ibogaine has attracted significant scientific attention for its remarkable ability to interrupt opioid addiction — reducing withdrawal symptoms and cravings in ways no other known substance can replicate. This therapeutic potential has made it one of the most intensely studied entheogens in modern pharmacology.

The Source: Tabernanthe iboga

Tabernanthe iboga is a slow-growing shrub that can reach 1.5–2 meters in height. The root bark contains the highest concentration of ibogaine, along with related alkaloids including ibogamine, tabernanthine, and voacangine. The plant takes 5–7 years to mature enough for its root bark to be harvested.

Other plants in the Apocynaceae family also contain iboga alkaloids, including Voacanga africanaand Tabernaemontana undulata, though at lower concentrations. Semi-synthetic ibogaine can also be derived from voacangine, offering a more sustainable production pathway.

  • •Tabernanthe iboga: Primary source, Central West Africa. Root bark used ceremonially.
  • •Voacanga africana: Contains voacangine, a precursor that can be converted to ibogaine.
  • •Tabernaemontana undulata: Contains trace amounts of iboga-type alkaloids.

Cultural & Ceremonial History

Iboga is central to the Bwiti spiritual tradition of Gabon, Cameroon, and the Republic of Congo. The Bwiti tradition — which may date back thousands of years — uses iboga root bark in initiation ceremonies where participants undergo extended visionary experiences to connect with ancestors and gain spiritual insight.

In Bwiti practice, iboga is not simply consumed — the ceremony involves days of preparation, communal singing and dancing, and careful guidance by experienced practitioners (N'ganga). The initiation ceremony typically involves consuming large amounts of root bark shavings over several hours, producing a profound 2–3 day experience considered a spiritual rebirth.

The Pygmy peoples of Central Africa are believed to have first discovered iboga's properties, possibly by observing animals eating the root. French colonizers documented iboga use as early as 1864, and the plant was formally identified by botanists in 1889. In 2000, the Council of Ministers of the Republic of Gabon declared iboga a national treasure and cultural heritage.

How Ibogaine Works

Ibogaine has one of the most complex pharmacological profiles of any known psychoactive compound. Rather than primarily targeting serotonin receptors like classical psychedelics (psilocybin, DMT, LSD), ibogaine interacts with multiple neurotransmitter systems simultaneously:

  • •NMDA receptors: Acts as a non-competitive antagonist, similar to ketamine, which may contribute to its anti-addictive effects.
  • •Opioid receptors: Binds to kappa and mu opioid receptors, which helps explain its ability to reduce opioid withdrawal symptoms.
  • •Serotonin system: Modulates serotonin transporters and 5-HT2A receptors, contributing to its psychedelic effects.
  • •Dopamine system: Influences dopamine pathways involved in reward and addiction.
  • •GDNF (Glial-Derived Neurotrophic Factor): Ibogaine increases GDNF expression, promoting neuronal growth and repair — a mechanism thought to "reset" addiction pathways.

After ingestion, ibogaine is metabolized in the liver into noribogaine, which has its own long-lasting pharmacological activity (half-life of 24–48 hours). Noribogaine is believed to be responsible for the sustained anti-craving effects that can last weeks to months after a single ibogaine session.

Therapeutic Research: Addiction Treatment

Ibogaine's most studied therapeutic application is in treating substance use disorders, particularly opioid addiction. The discovery of ibogaine's anti-addictive properties is credited to Howard Lotsof, a heroin user who, in 1962, found that a single dose of ibogaine eliminated his withdrawal symptoms and desire for heroin.

Key findings from published research include:

  • •Opioid withdrawal: Multiple observational studies report significant reduction in withdrawal symptoms within 12–24 hours of administration.
  • •Craving reduction: Sustained reduction in drug cravings lasting weeks to months after a single treatment.
  • •Alcohol and stimulant dependence: Emerging evidence suggests benefit for alcohol, cocaine, and methamphetamine addiction.
  • •Depression and PTSD: Preliminary studies show improvements in depression and trauma symptoms, though more research is needed.
  • •Arizona funding: The state of Arizona earmarked $5 million for ibogaine research in its FY2026 budget, signaling growing institutional interest.

Several clinical trials are underway globally, including studies at academic institutions in the United States, Brazil, and Spain. The non-profit organization MAPS (Multidisciplinary Association for Psychedelic Studies) has supported ibogaine research, and various companies are developing ibogaine analogs designed to retain therapeutic effects while reducing cardiac risk.

The Experience

An ibogaine experience is unlike any other psychedelic. It unfolds in distinct phases:

  • •
    Onset (1–3 hours): A buzzing or vibrating sensation, ataxia (difficulty with coordination), and the beginning of visual effects. Many describe hearing a characteristic "buzzing" sound.
  • •
    Visionary phase (4–8 hours): Vivid, panoramic visions — often described as watching a movie of one's life. Many report revisiting childhood memories, encountering archetypal imagery, and receiving profound personal insights. Unlike other psychedelics, eyes are typically closed and the experience is primarily internal.
  • •
    Introspective phase (8–20 hours): The visions fade but deep cognitive processing continues. Many people describe understanding the root causes of their behavioral patterns and addictions during this phase.
  • •
    Recovery (24–72 hours): Gradual return to baseline. Sleep is difficult for 1–2 days. Many report a sense of emotional clarity and renewed purpose. Physical coordination returns slowly.

Legal Status

Ibogaine occupies a complex legal landscape globally:

  • •Washington, D.C.: Covered under Initiative 81 as an entheogenic plant substance, making it among the lowest law enforcement priorities.
  • •United States (federal): Ibogaine is a Schedule I controlled substance under federal law.
  • •Colorado: Proposition 122 (2022) decriminalized ibogaine along with psilocybin, DMT, and mescaline.
  • •Mexico, Costa Rica, Brazil: Ibogaine is unregulated and treatment clinics operate legally.
  • •New Zealand: Available by prescription since 2009 as an unapproved medicine.
  • •Gabon: Declared a national cultural heritage in 2000; legal for traditional use.

Critical Safety Information

Ibogaine carries serious medical risks that distinguish it from other psychedelics. It should never be taken without medical supervision and cardiac screening:

  • •Cardiac risk: Ibogaine affects the heart's QT interval and has been associated with fatalities due to cardiac arrhythmia. A thorough cardiac evaluation (EKG) is essential before use.
  • •Liver function: Ibogaine is metabolized by the liver; pre-existing liver conditions significantly increase risk.
  • •Drug interactions: Dangerous interactions with opioids, methadone, SSRIs, antipsychotics, and many other medications. A drug-free washout period is critical.
  • •Medical supervision: Ibogaine should only be administered in a medically supervised setting with cardiac monitoring, trained staff, and emergency equipment.
  • •Duration: The 24–36 hour experience requires continuous monitoring and support.

This content is for educational purposes only and does not constitute medical advice. Paradise Farmers Market promotes harm reduction through accurate information.